2022. The efficacy of Palivizumab prophylaxis for acute respiratory syncytial virus infections in at-risk populations: a literature review. Revista Eletrônica Acervo Médico. 17, (Sep. 2022), e10854. DOI:https://doi.org/10.25248/reamed.e10854.2022.